Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective
Xin Chen, Junjie Xu, Xianghan Wang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 10537-10556
Closed Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials
Xin Xie, Tingting Yu, Xiang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 158
Tracking the PROTAC degradation pathway in living cells highlights the importance of ternary complex measurement for PROTAC optimization
Martin P. Schwalm, Andreas Krämer, Anja Dölle, et al.
Cell chemical biology (2023) Vol. 30, Iss. 7, pp. 753-765.e8
Open Access | Times Cited: 47
Discovery of Potent Small-Molecule Inhibitors of WDR5-MYC Interaction
Jian Ding, Guo Li, Hejun Liu, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 1, pp. 34-40
Closed Access | Times Cited: 25
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer
Xufen Yu, Dongxu Li, Jithesh Kottur, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16168-16186
Closed Access | Times Cited: 19
WIN site inhibition disrupts a subset of WDR5 function
Andrew J. Siladi, Jing Wang, Andrea C. Florian, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 24
Discovery of Potent Orally Bioavailable WD Repeat Domain 5 (WDR5) Inhibitors Using a Pharmacophore-Based Optimization
Kevin B. Teuscher, Kenneth M. Meyers, Qiangqiang Wei, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 8, pp. 6287-6312
Open Access | Times Cited: 24
Pocket Crafter: a 3D generative modeling based workflow for the rapid generation of hit molecules in drug discovery
Lingling Shen, Jian Fang, Lulu Liu, et al.
Journal of Cheminformatics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Synergistic effects of the KDM4C inhibitor SD70 and the menin inhibitor MI‐503 against MLL::AF9‐driven acute myeloid leukaemia
Wenqi Zhu, Yiyi Ding, Wanling Huang, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 2, pp. 568-579
Closed Access | Times Cited: 5
Structure-based discovery of potent WD repeat domain 5 inhibitors that demonstrate efficacy and safety in preclinical animal models
Kevin B. Teuscher, Somenath Chowdhury, Kenneth M. Meyers, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 120, Iss. 1
Open Access | Times Cited: 22
Cyclic mechanical stress promotes osteogenic differentiation of periodontal ligament stem cells via KAT2A-mediated succinylation of WDR5
Xiaofeng Guo, Nanshan Zhuge
Tissue and Cell (2025) Vol. 95, pp. 102839-102839
Closed Access
Immunoproteomic Analyses Identify Broadly Cross-reactive Sporozoite Immunogens of Eimeria maxima recognized by antisera from chickens infected with E. maxima, E. necatrix, E. tenella or E. acervulina
Haiwei Gong, Haiying Deng, Feng Song, et al.
Veterinary Parasitology (2025), pp. 110462-110462
Closed Access
Crystal structures of Kif2A complexed with WDR5 reveal the structural plasticity of WIN-S7 sites
Yang Yang, Shuting Zhang, Z. J. Wu, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)–MYC Interaction
Jian Ding, Lulu Liu, Ying‐Ling Chiang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 8310-8323
Closed Access | Times Cited: 10
Recent Progress in Modulation of WD40-Repeat Domain 5 Protein (WDR5): Inhibitors and Degraders
Raju Gurung, Darlami Om, R.Y.K. Pun, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3910-3910
Open Access | Times Cited: 10
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5
Yanran Chen, Haomiao Su, Jianing Zhao, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113145-113145
Open Access | Times Cited: 10
Small molecule and peptide inhibitors of βTrCP and the βTrCP–NRF2 protein–protein interaction
Uzma Jaffry, Geoffrey Wells
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 925-936
Open Access | Times Cited: 7
Discovery and Optimization of WDR5 Inhibitors via Cascade Deoxyribonucleic Acid-Encoded Library Selection Approach
Shaozhao Qin, Lijian Feng, Qingyi Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1079-1092
Closed Access | Times Cited: 2
The NTE domain of PTENα/β promotes cancer progression by interacting with WDR5 via its SSSRRSS motif
Xiaolei Huang, Cheng Zhang, Xinci Shang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 5
Open Access | Times Cited: 2
Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors
Kevin B. Teuscher, Jonathan J. Mills, Jianhua Tian, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16783-16806
Closed Access | Times Cited: 4
Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8
Tingting Wu, Yali Chen, Qidong You, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116271-116271
Closed Access | Times Cited: 1
Structural studies of WDR5 in complex with MBD3C WIN motif reveal a unique binding mode
Yang Yang, Li Xu, Shuting Zhang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 7, pp. 107468-107468
Open Access | Times Cited: 1
NSUN5 Facilitates Hepatocellular Carcinoma Progression by Increasing SMAD3 Expression
Hexu Han, Chengcheng Zhang, Wenbo Shi, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
Liquid-liquid phase separation in viral infection: from the occurrence and function to treatment potentials
Zheng Cao, Yanhua Yang, Simeng Zhang, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 246, pp. 114385-114385
Closed Access | Times Cited: 1
The WD repeat-containing protein 5 (WDR5) antagonist WDR5-0103 restores the efficacy of cytotoxic drugs in multidrug-resistant cancer cells overexpressing ABCB1 or ABCG2
Chung‐Pu Wu, Ya‐Ju Hsieh, Han-Yu Tseng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113663-113663
Open Access | Times Cited: 7
Mechanism of Resistance to the WDR5 Inhibitor in MLL-Rearranged Leukemia
Lulu Liu, Lingling Shen, Zhilou Ding, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 4, pp. 949-958
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top